Fluorouracil News and Research

RSS
Fluorouracil is a drug used to treat symptoms of cancer of the colon, breast, stomach, and pancreas. It is also used in a cream to treat certain skin conditions. Fluorouracil stops cells from making DNA and it may kill cancer cells. It is a type of antimetabolite. Also called 5-fluorouracil and 5-FU.
Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park receives more than $15 million in grants for cancer research

Scientists discover how resistance to the chemotherapy drug 5-fluorouracil arises

Scientists discover how resistance to the chemotherapy drug 5-fluorouracil arises

New drug combinations and dosing schedules improve outlook in advanced colon cancer

New drug combinations and dosing schedules improve outlook in advanced colon cancer

New cell co-culture platform holds promise for future of personalized medicine

New cell co-culture platform holds promise for future of personalized medicine

Study finds no statistically significant effect of drug shortages on cancer treatment

Study finds no statistically significant effect of drug shortages on cancer treatment

Combination of two topical creams can prevent cancer

Combination of two topical creams can prevent cancer

Study provides information about chemotherapeutic drugs binding to plasma proteins

Study provides information about chemotherapeutic drugs binding to plasma proteins

Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer

Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer

Study findings could set new standard of care for advanced anal cancer

Study findings could set new standard of care for advanced anal cancer

Aluminum inclusions help enhance adsorption of chemo drugs onto active carbon delivery capsule

Aluminum inclusions help enhance adsorption of chemo drugs onto active carbon delivery capsule

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Researchers develop technology to program DNA for delivering cancer drugs

Researchers develop technology to program DNA for delivering cancer drugs

Older patients with colorectal cancer at increased risk of cardiovascular morbidity

Older patients with colorectal cancer at increased risk of cardiovascular morbidity

Genentech researchers uncover epigenetic regulator of pancreatic cancer cells

Genentech researchers uncover epigenetic regulator of pancreatic cancer cells

Clinical trial shows promising results for treatment of patients with recurrent high-grade glioma

Clinical trial shows promising results for treatment of patients with recurrent high-grade glioma

New topical treatment to combat skin cancer yields promising results in preliminary study

New topical treatment to combat skin cancer yields promising results in preliminary study

FDA grants approval for new biosimilar to treat multiple types of cancer

FDA grants approval for new biosimilar to treat multiple types of cancer

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

ASTRO issues new clinical guideline for management of oropharyngeal cancer with radiation therapy

ASTRO issues new clinical guideline for management of oropharyngeal cancer with radiation therapy